Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

MedWellAI (MWAI) EBIT Margin (2016 - 2025)

MedWellAI (MWAI) has disclosed EBIT Margin for 11 consecutive years, with 27.97% as the latest value for Q4 2025.

  • On a quarterly basis, EBIT Margin rose 19260.0% to 27.97% in Q4 2025 year-over-year; TTM through Dec 2025 was 32.07%, a 19884.0% increase, with the full-year FY2025 number at 133.44%, changed N/A from a year prior.
  • EBIT Margin was 27.97% for Q4 2025 at MedWellAI, up from 339.29% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 1331.92% in Q2 2021 to a low of 51305.23% in Q3 2024.
  • A 5-year average of 2770.57% and a median of 128.46% in 2024 define the central range for EBIT Margin.
  • Peak YoY movement for EBIT Margin: crashed -5045005bps in 2024, then soared 5096594bps in 2025.
  • MedWellAI's EBIT Margin stood at 13.03% in 2021, then plummeted by -1166bps to 164.91% in 2022, then surged by 88bps to 19.42% in 2023, then tumbled by -1035bps to 220.56% in 2024, then soared by 87bps to 27.97% in 2025.
  • Per Business Quant, the three most recent readings for MWAI's EBIT Margin are 27.97% (Q4 2025), 339.29% (Q3 2025), and 1245.09% (Q2 2025).